United Therapeutics CorporationSilver Spring, MD, United States (NASDAQ (GS): UTHR)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Company Description

Hoover's coverage by Anne Law

United Therapeutics hopes its products will be in vein. Its intravenous drug Remodulin treats pulmonary hypertension, which affects the blood...

Full Company Description for United Therapeutics

Headquarters:

1110 Spring St.
Silver Spring, MD 20910
United States  (Map)

More United Therapeutics Locations & Contact Info

Key United Therapeutics Financials

Company Type Public - NASDAQ (GS): UTHR
Main Headquarters
Fiscal Year-End December
2007 Sales (mil.) $210.9
2006 Employees 285

More United Therapeutics Financials (11 pages)

Latest United Therapeutics Jobs jobs by Indeed

Rankings

  • S&P 400

Competition

Competitive Landscape for Chemicals

Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...

Read more about United Therapeutics's competition across multiple industries

Top United Therapeutics Competitors

Editor-Selected Competitor List For United Therapeutics

United Therapeutics Executives

Title Name & Bio Contact
Chairman and CEO Martine A. Rothblatt Network | E-mail
President, COO, and Director Roger Jeffs Network | E-mail
CFO and Treasurer John M. Ferrari Network | E-mail

More United Therapeutics Executives

Are You Listed On Hoover's?
Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record.

Network With People At United Therapeutics

Tools from our advertising partners:

Sponsored Opportunity